| J0585 | Injection, onabotulinumtoxina, 1 unit | 42,300 | $10 | $211.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 880 | $110 | $92.1K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 140 | $190 | $27.2K |
| 64616 | The provider administers a chemical compound to the neck muscles on one side, avoiding the laryngeal muscles. The goal of this procedure is to paralyze the muscles. Providers may treat cervical… | 140 | $190 | $26K |
| 64612 | In this procedure, the provider injects a chemical on one side of the face to disable the facial nerve and relieve painful facial nerve disorders or abnormal involuntary movements of facial muscles. | 150 | $150 | $23.4K |
| J0587 | Injection, rimabotulinumtoxinb, 100 units | 1,780 | $10 | $17.8K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 50 | $150 | $7.6K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 50 | $110 | $4.9K |
| 64611 | The provider administers a chemical compound to the parotid and submandibular salivary glands bilaterally to decrease the amount of saliva produced and reduce the risk of aspiration. | 30 | $120 | $4K |
| 99223 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 20 | $160 | $3.3K |